Online Database of Chemicals from Around the World

(6beta,11beta)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
[CAS# 1048031-82-8]

Identification
Name (6beta,11beta)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
Molecular Structure CAS # 1048031-82-8, (6beta,11beta)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
Molecular Formula C24H32O6
Molecular Weight 416.51
CAS Registry Number 1048031-82-8
Properties
Solubility Practically insoluble (0.015 g/L) (25 ºC), Calc.*
Density 1.26±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)
Market Analysis Reports
List of Reports Available for (6beta,11beta)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
Related Products
(5alpha)-3-(Acetyloxy)-17-(cyclopropylmethyl)-4,5-epoxy-14-[[[[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]amino]carbonyl]oxy]morphinan-6-one  (3beta,5alpha,11alpha,12beta,14beta,17alpha,)-12-(Acetyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-beta-D-allopyranosyl)-3-O-methyl-beta-D-arabino-hexopyranosyl]oxy]-8,14-epoxy-11-(2-methyl-1-oxopropoxy)-pregnan-20-one  2-Acetyloxy-1-(2,4-difluorophenyl)ethanone  (2E)-(+)-3-[5-(Acetyloxy)-4,5-dihydro-3-furanyl]-N-(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-2-propenamide  (11beta,16beta)-21-(Acetyloxy)-5',16-dihydro-11-hydroxy-pregna-1,4-dieno[17,16-c]pyrazole-3,20-dione  (2S,3S)-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one  (2S-cis)-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-5-[2-(methylamino)ethyl]-1,5-benzothiazepin-4(5H)-one monohydrochloride  5-(Acetyloxy)-4,5-dihydro-2-methyl-3-furancarboxylic acid methyl ester  4-(Acetyloxy)-3,4-dihydro-1(2H)-naphthalenone  (2R,3S,6S)-3-(Acetyloxy)-3,6-dihydro-6-[2-(trimethylsilyl)ethynyl]-2H-pyran-2-methanol 2-acetate  12-(Acetyloxy)-3,6-dihydroxy-7-oxocholan-24-oic acid methyl ester  (3alpha,5beta)-3-(Acetyloxy)-17,21-dihydroxy-pregnane-11,20-dione  3-[4-(Acetyloxy)-3,5-dimethoxycinnamic acid  (2R-trans)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one monohydrochloride  (2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 1-oxide  (11alpha)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione  6-[(3R,4R)-3-(Acetyloxy)-N,4-dimethyl-6-oxo-L-norleucine]-cyclosporin A  1-Acetyloxy-2,5-dioxopyrrolidine-3-sulfonic acid  (3beta,5beta,15beta,16beta)-16-(Acetyloxy)-14,15-epoxy-3,5-dihydroxy-19-oxobufa-20,22-dienolide  (3alpha,7alpha)-3-(Acetyl-d3-oxy)-12,13-epoxy-7,15-dihydroxytrichothec-9-en-8-one